Inhibitory Effects of Omega-3 PUFAs on Cardiac Fibrosis in Vivo and in Vitro
Jinghai Chen,Gregory Shearer,Timothy D. O'Connell,A. Martin Gerdes,William S. Harris,Dajun Wang
DOI: https://doi.org/10.1016/j.cardfail.2009.06.382
IF: 6.592
2009-01-01
Journal of Cardiac Failure
Abstract:Introduction: Many studies have shown that omega-3 polyunsaturated fatty acids (ω-3 PUFAs) have beneficial effects on cardiovascular disease but little is known about the effects of ω-3 PUFAs on cardiac fibrosis, which is the major cause of cardiac remodeling leading to hear failure. Hypothesis: ω-3 PUFAs will inhibit cardiac fibrosis and improve heart function. Methods: Ten weeks old male C57/B6 mice were fed control diet (corn oil, ω-6 PUFAs; n=20) or Fish oil diet (FO) 1% energy from EPA+DHA (n=20). After 8 weeks on the assigned diet, Sham or Transverse Aortic Constriction (TAC) surgery will be randomly performed on each diet group. The groups allocated in a 2x2 factorial design into 4 groups as (1) Cont/Sham, (2) Cont/TAC, (3) FO/Sham, (4) FO/TAC. After 4 weeks of continued dietary, myocardial fibrosis was determined by picro-sirius red staining for collagen in the middle of left ventricle. The ω-3 index (the sum of red blood cell EPA + DHA) were determined by gas chromatography. Echocardiography (Echo) were also performed on mice one day before and 2- and 4-weeks post-surgery. In vitro experiments were performed in adult cardiac fibroblasts (CFs) isolated from the heart of male C57BL/6 mice. CFs collagen synthesis, differentiation to myofibroblasts and proliferation were determined by 3H-proline incorporation, α-smooth muscle actin (α-SMA) staining and MTS assay, respectively. Results: Compare to Cont/sham group, in Cont/TAC group, Fractional Shortening (FS) were decreased significantly (p<0.01) as well as myocardial fibrosis was significantly increased in (p<0.01) at 4 weeks. However, FO treatment rescued the effects of TAC stress as FS remarkably reverse (FO/ TAC 45%±10% vs Cont/TAC 28%±10%, p<0.01) and myocardial fibrosis significantly decreased (FO/ TAC 8.9%±2.8% vs Cont/TAC 14.1%±4.1%, p<0.01). In addition, the ω-3 index was notably increased in FO diet group (FO 15.17%±0.4% vs Cont 3.9%± 0.6%, p<0.01). In vitro, EPA and DHA (10 μM) significantly blocked the pro-fibrotic effects of TGF- β1 (1ng/mL) on collagen synthesis while arachidonic acid (AA) and oleic acid (OA) did not. Both EPA and DHA suppressed TGF- β1-induced differentiation of CFs to myofibroblasts. Furthermore, EPA and DHA (1 to 50 μM) inhibited CFs proliferation induce by both Angiotensin II (100 nM) and TGF- β1 (1ng/mL) more than AA (p<0.01) and OA (p<0.05) did. Conclusion: Both in vivo and in vitro. ω-3 PUFAs have the potential to inhibit the development of cardiac fibrosis.